(3R,4R,5S)-4-acetamido-5-amino-N-(2-(1-(4-bromobenzyl)-1H-1,2,3-triazol-4-yl)propan-2-yl)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxamide

ID: ALA4438764

Chembl Id: CHEMBL4438764

PubChem CID: 155513230

Max Phase: Preclinical

Molecular Formula: C26H37BrN6O3

Molecular Weight: 561.53

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)NC(C)(C)c2cn(Cc3ccc(Br)cc3)nn2)C[C@H](N)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C26H37BrN6O3/c1-6-20(7-2)36-22-13-18(12-21(28)24(22)29-16(3)34)25(35)30-26(4,5)23-15-33(32-31-23)14-17-8-10-19(27)11-9-17/h8-11,13,15,20-22,24H,6-7,12,14,28H2,1-5H3,(H,29,34)(H,30,35)/t21-,22+,24+/m0/s1

Standard InChI Key:  BNLICTDYHDAMBF-WMTXJRDZSA-N

Alternative Forms

  1. Parent:

    ALA4438764

    ---

Associated Targets(non-human)

NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 561.53Molecular Weight (Monoisotopic): 560.2111AlogP: 3.18#Rotatable Bonds: 10
Polar Surface Area: 124.16Molecular Species: BASEHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.20CX Basic pKa: 9.11CX LogP: 3.19CX LogD: 1.49
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.41Np Likeness Score: -0.32

References

1. Ju H, Xiu S, Ding X, Shang M, Jia R, Huang B, Zhan P, Liu X..  (2020)  Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.,  187  [PMID:31835169] [10.1016/j.ejmech.2019.111940]

Source